Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H9N3O2 |
| Molecular Weight | 179.176 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)NNC(=O)C1=CC=NC=C1
InChI
InChIKey=CVBGNAKQQUWBQV-UHFFFAOYSA-N
InChI=1S/C8H9N3O2/c1-6(12)10-11-8(13)7-2-4-9-5-3-7/h2-5H,1H3,(H,10,12)(H,11,13)
| Molecular Formula | C8H9N3O2 |
| Molecular Weight | 179.176 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Evaluation of hepatoprotective activity of Cissus quadrangularis stem extract against isoniazid-induced liver damage in rats. | 2010-12 |
|
| Is there any difference between acetylator phenotypes in tuberculosis patients and healthy subjects? | 2010-03 |
|
| [High-performance liquid chromatography for detecting the concentrations of isoniazid and acetylisoniazid in spinal tuberculosis]. | 2010-02 |
|
| Simultaneous determination of isoniazid, pyrazinamide, rifampicin and acetylisoniazid in human plasma by high-performance liquid chromatography. | 2010 |
|
| Estimating N-acetyltransferase metabolic activity and pharmacokinetic parameters of isoniazid from genotypes in Chinese subjects. | 2009-07 |
|
| Effects of N-acetyltransferase 2 (NAT2), CYP2E1 and Glutathione-S-transferase (GST) genotypes on the serum concentrations of isoniazid and metabolites in tuberculosis patients. | 2008-05 |
|
| Low serum concentrations of anti-tuberculosis drugs and determinants of their serum levels. | 2007-09 |
|
| The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats. | 2007-09 |
|
| Quantification of isoniazid and acetylisoniazid in rat plasma and alveolar macrophages by liquid chromatography-tandem mass spectrometry with on-line extraction. | 2007-03-01 |
|
| [Detection of mutation in NAT II gene as a method of determination of izoniazyd (INH) acetylation type in human population]. | 2007 |
|
| Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry. | 2007 |
|
| Tuberculosis chemotherapy: current drug delivery approaches. | 2006-09-19 |
|
| The influence of NAT2 genotypes on the plasma concentration of isoniazid and acetylisoniazid in Chinese pulmonary tuberculosis patients. | 2006-03 |
|
| Microparticle-based lung delivery of INH decreases INH metabolism and targets alveolar macrophages. | 2005-10-03 |
|
| Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase. | 2005-01-15 |
|
| Unchanged acetylation of isoniazid by alcohol intake. | 2004-11 |
|
| The effects of acute ethanol intake on isoniazid pharmacokinetics. | 2004-11 |
|
| Solid-phase extraction and HPTLC determination of isoniazid and acetylisoniazid in serum. Comparison with HPLC. | 2004-06-11 |
|
| Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe. | 2002-12 |
|
| Determination of antitubercular drugs in urine and pharmaceuticals by LC using a gradient flow combined with programmed diode array photometric detection. | 2002-08-23 |
|
| A simplified method for detecting isoniazid compliance in patients receiving antituberculosis chemotherapy. | 2002-02 |
|
| Therapeutic isoniazid monitoring using a simple high-performance liquid chromatographic method with ultraviolet detection. | 2002-01-05 |
|
| Increased urinary excretion of toxic hydrazino metabolites of isoniazid by slow acetylators. Effect of a slow-release preparation of isoniazid. | 1987 |
|
| Antituberculous compounds. 23. Alkyl- and acylisonicotinic acid hydrazides. | 1965-11 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:48:23 GMT 2025
by
admin
on
Mon Mar 31 18:48:23 GMT 2025
|
| Record UNII |
J42942UVUN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C510884
Created by
admin on Mon Mar 31 18:48:23 GMT 2025 , Edited by admin on Mon Mar 31 18:48:23 GMT 2025
|
PRIMARY | |||
|
DTXSID1020013
Created by
admin on Mon Mar 31 18:48:23 GMT 2025 , Edited by admin on Mon Mar 31 18:48:23 GMT 2025
|
PRIMARY | |||
|
71602
Created by
admin on Mon Mar 31 18:48:23 GMT 2025 , Edited by admin on Mon Mar 31 18:48:23 GMT 2025
|
PRIMARY | |||
|
J42942UVUN
Created by
admin on Mon Mar 31 18:48:23 GMT 2025 , Edited by admin on Mon Mar 31 18:48:23 GMT 2025
|
PRIMARY | |||
|
1078-38-2
Created by
admin on Mon Mar 31 18:48:23 GMT 2025 , Edited by admin on Mon Mar 31 18:48:23 GMT 2025
|
PRIMARY | |||
|
7207
Created by
admin on Mon Mar 31 18:48:23 GMT 2025 , Edited by admin on Mon Mar 31 18:48:23 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE INACTIVE |
|
